Table 4.

Multivariable logistic binary regression models for sexual dysfunction in three SexFS domains and for reproductive concerns in at least one dimension of the RCAC

	Vaginal Lubricationa		Vaginal Discomfortb		Satisfaction with Sex Lifec		RCACd
Predictor variablese	OR	95% CI	OR	95% CI	OR	95% CI	OR	95% CI
Age
‐35(ref)	‐	‐	‐	‐	‐	‐	‐	‐
36‐40	1.42	0.42‐4.76	0.56	0.13‐2.49	1.12	0.34‐3.72	1.25	0.43‐3.57
41‐	1.17	0.30‐4.58	0.09 *	0.01‐0.70	0.55	0.13‐2.36	0.84	0.26‐2.76
Education
‐university degree	0.95	0.35‐2.59	8.80 *	1.69‐45.86	2.86	0.95‐8.60	1.59	0.67‐3.80
Wish for (additional) children	2.24	0.67‐7.48	0.48	0.08‐2.88	0.66	0.19‐2.27	3.40 *	1.14‐10.17
Previous chemo‐therapy	0.58	0.22‐1.56	0.78	0.21‐2.87	1.32	0.48‐3.63	2.51 *	1.06‐5.95
Current endocrine treatment	3.80 *	1.19‐12.10	8.74 *	1.48‐51.45	1.99	0.63‐6.25	1.26	0.55‐2.88
BIS	0.99	0.91‐1.10	0.98	0.88‐1.10	1.09 *	1.01‐1.18	1.05	0.98‐1.12
QLQ‐30‐v2	0.96 *	0.93‐0.99	0.90 **	0.85‐0.95	0.96 **	0.93‐0.99	0.97 *	0.94‐1.00

Note:

Statistically significant predictors (p < 0.05) indicated in bold.

^aNagelkerke R ² = .25.

^bNagelkerke R ² = .52.

^cNagelkerke R ² = .33.

^dNagelkerke R ² = .28.

^eNon‐significant variables: employment status, birth‐country, have children, current partner relationship, days since diagnosis, previous cancer treatment (radiation therapy, targeted therapy), distant metastases, mastectomy, menstruation status, fertility preservation, and satisfaction with sex‐life before cancer.

^* p < 0.05.

^** p < 0.001.